Back to newsPulse Biosciences: Canaccord Genuity raises target price to $74 from $58PPLSE•2026-11-06Canaccord Genuity raised its target price for Pulse Biosciences to $74 from $58.Related NewsTInterface Q3 EPS USD 0.67TILE•2026-11-06EGermany's fiscal boost is taking holdEWG•2026-11-06SNasdaq futures rise after steep AI selloff as chip stocks stabilizeSPY•2026-11-06TBarclays cuts Tripadvisor target price to $8 from $9TRIP•2026-11-06FFortis cuts to equal-weight from overweight; target price raised to $61 from $56FTS•2026-11-06